Expression of the common heat‐shock protein receptor CD91 is increased on monocytes of exposed yet HIV‐1‐seronegative subjects

The significantly higher surface expression of the surface heat‐shock protein receptor CD91 on monocytes of human immunodeficiency virus type‐1 (HIV‐1)‐infected, long‐term nonprogressors suggests that HIV‐1 antigen uptake and cross‐presentation mediated by CD91 may contribute to host anti‐HIV‐1 defenses and play a role in protection against HIV‐1 infection. To investigate this further, we performed phenotypic analysis to compare CD91 surface expression on CD14+ monocytes derived from a cohort of HIV‐1‐exposed seronegative (ESN) subjects, their seropositive (SP) partners, and healthy HIV‐1‐unexposed seronegative (USN) subjects. The median fluorescent intensity (MFI) of CD91 on CD14+ monocytes was significantly higher in ESN compared with SP (P=0.028) or USN (P=0.007), as well as in SP compared with USN subjects (P=0.018). CD91 MFI was not normalized in SP subjects on highly active antiretroviral therapy (HAART) despite sustainable, undetectable plasma viraemia. Data in three SP subjects experiencing viral rebounds following interruption of HAART showed low CD91 MFI comparable with levels in USN subjects. There was a significant positive correlation between CD91 MFI and CD8+ T cell counts in HAART‐naïve SP subjects (r=0.7, P=0.015). Increased surface expression of CD91 on CD14+ monocytes is associated with the apparent HIV‐1 resistance that is observed in ESN subjects.

[1]  H. Pandha,et al.  The common heat shock protein receptor CD91 is up‐regulated on monocytes of advanced melanoma slow progressors , 2004, Clinical and experimental immunology.

[2]  B. Walker,et al.  Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II1 , 2004, The Journal of Immunology.

[3]  P. Kaleebu,et al.  HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans. , 2004, AIDS research and human retroviruses.

[4]  P. Kaleebu,et al.  Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals. , 2004, The Journal of infectious diseases.

[5]  B. Gazzard,et al.  Where does HIV live? , 2004, The New England journal of medicine.

[6]  S. Pizzo,et al.  A CD91-Positive Subset of CD11c+ Blood Dendritic Cells: Characterization of the APC that Functions to Enhance Adaptive Immune Responses against CD91-Targeted Antigens 1 , 2004, The Journal of Immunology.

[7]  B. Gazzard,et al.  All for CD91 and CD91 for all. , 2003, The Journal of antimicrobial chemotherapy.

[8]  J. Nick,et al.  By Binding SIRPα or Calreticulin/CD91, Lung Collectins Act as Dual Function Surveillance Molecules to Suppress or Enhance Inflammation , 2003, Cell.

[9]  B. Gazzard,et al.  Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. , 2003, Blood.

[10]  B. Gazzard,et al.  The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors. , 2003, Blood.

[11]  A. Al-Mehdi,et al.  Human α-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor–related protein/α2-macroglobulin receptor , 2002 .

[12]  C. Hallahan,et al.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.

[13]  E. Dalmasso,et al.  Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor , 2002, Science.

[14]  M. Lederman,et al.  HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens , 2002, AIDS.

[15]  J. Luban,et al.  Specific Incorporation of Heat Shock Protein 70 Family Members into Primate Lentiviral Virions , 2002, Journal of Virology.

[16]  P. Srivastava.  Roles of heat-shock proteins in innate and adaptive immunity , 2002, Nature Reviews Immunology.

[17]  H. Udono,et al.  Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. , 2001, International immunology.

[18]  C. Nicchitta,et al.  Virally Induced Lytic Cell Death Elicits the Release of Immunogenic GRP94/gp96* , 2001, The Journal of Biological Chemistry.

[19]  A. Sette,et al.  Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. , 2001, Human immunology.

[20]  P. Srivastava,et al.  CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. , 2001, Immunity.

[21]  P. Srivastava,et al.  Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. , 2000, International immunology.

[22]  P. Srivastava,et al.  CD91: a receptor for heat shock protein gp96 , 2000, Nature Immunology.

[23]  H. Rammensee,et al.  Cross-Presentation of Glycoprotein 96–Associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-Mediated Endocytosis , 2000, The Journal of experimental medicine.

[24]  Maltseva,et al.  Tissue distribution of rat macroglobulins in tumour‐bearing rats , 1999, International journal of experimental pathology.

[25]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[26]  S. Kent,et al.  Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long‐term survivors of transfusion‐acquired HIV‐1 infection , 1997, AIDS.

[27]  P. Sax.  Long-Term Nonprogressors , 1997 .

[28]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[29]  J. Coffin,et al.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.

[30]  J. Margolick,et al.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[31]  S. Buchbinder,et al.  Long‐term HIV‐1 infection without immunologic progression , 1994, AIDS.

[32]  P. Srivastava,et al.  Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[34]  G. Rutherford,et al.  Progression and clinical outcome of infection due to human immunodeficiency virus. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  D. Burke,et al.  Natural history of human immunodeficiency virus infection. , 1991, Dermatologic clinics.

[36]  N. Bowern,et al.  Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin. , 1991, Immunology.